INVIVOSCRIBE INC.

In News

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification - Business Wire

Business Wire - Mar 26, 2026

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA - BioSpace

BioSpace - Jul 21, 2023

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia - PR Newswire

PR Newswire - Jul 14, 2020

Cancer Biomarkers Market Report 2026-2032, By Product, Profiling Technology, and Geo - MarketsandMarkets

MarketsandMarkets - May 18, 2026

Genection: New Personalized Molecular Medicine Company - Clinical Lab Products

Clinical Lab Products - Sep 29, 2020

Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML - aap.com.au

aap.com.au - Oct 24, 2022

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care - STT Info

STT Info - Aug 04, 2026

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

PR Newswire - Aug 16, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment